Posted By:
Steve Parcell
Category:
General
A recent European study concluded that niacin (nicotinic acid, B3) had too many side effects and is not worth using. The media quickly got on board to spread the news. The study was funded by Merck pharmaceuticals, the makers of the statin drug Zocor. Two grams of extended-release niacin and 40 mg of laropiprant or a matching placebo daily was given. The primary outcome was the first major vascular event (nonfatal myocardial infarction, deat...